Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 4, 2018
Zogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut Syndrome
EMERYVILLE, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
September 4, 2018
Catalyst Biosciences Announces Publication of Marzeptacog Alfa (Activated) Phase 1 Data in The Journal of Thrombosis and Haemostasis
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
September 4, 2018
Pfenex to Present at the Liolios 7th Annual Gateway Conference
SAN DIEGO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) announced today that it will be presenting at the Liolios 7th Annual ...
September 4, 2018
BrainStorm Appoints Arturo Araya as Chief Commercial Officer
NEW YORK and PETACH TIKVAH, Israel, Sept. 04, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, ...
August 27, 2018
Arcturus Therapeutics to Present at Three Investor Conferences in September
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced that Joseph E. Payne will present ...
August 27, 2018
ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 27, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (the “Company”), a vertically integrated commercial biopharmaceutical company that ...
August 27, 2018
Tyme Technologies, Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced that it will ...
August 27, 2018
Brainsway Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update
HACKENSACK, N.J., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Brainsway Ltd. (BRIN.TA), a leader in the advanced non-invasive treatment of brain disorders, today announced the Company’s ...
August 27, 2018
Pernix Therapeutics Announces Ruling in Patent Litigation Concerning Zohydro® ER with BeadTek®
MORRISTOWN, N.J., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today that in the Company’s litigation against ...
August 27, 2018
Eiger BioPharmaceuticals to Participate in Investor Conferences
PALO ALTO, Calif., Aug. 27, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
August 27, 2018
STRATA Skin Sciences to Participate in H.C. Wainwright’s 20th Annual Global Investment Conference
HORSHAM, Pa., Aug. 27, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
August 27, 2018
Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 SSIEM Annual Symposium
AUSTIN, Texas, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
August 21, 2018
BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
RALEIGH, N.C., Aug. 21, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with chronic ...
August 20, 2018
Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss
MONTPELLIER, France, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Sensorion(FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announces that ...
August 20, 2018
AC Immune Announces Important Clinical Milestones for ACI-24 Vaccine in Alzheimer's Disease and Down Syndrome
Lausanne, Switzerland, August 20, 2018 - AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced ...
August 20, 2018
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 20, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty ...
August 20, 2018
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive-Compulsive Disorder
HACKENSACK, N.J., Aug. 20, 2018 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRIN.TA), the parent company of BrainsWay USA, Inc., and a global leader in the advanced ...
August 20, 2018
HTG Molecular Announces 2nd Amendment to Second Statement of Work with QIAGEN Manchester Limited
TUCSON, Ariz., Aug. 20, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, ...
August 20, 2018
STRATA Skin Sciences Announces Strategic Agreement with a Large Private Equity Backed Group of Dermatology Clinics
HORSHAM, Pa., Aug. 20, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
August 20, 2018
Athenex Appoints Randoll Sze as Chief Financial Officer
BUFFALO, N.Y., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
Page 21 of 117